• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Pembrolizumab-Induced Extensive Panniculitis and Nevus Regression: Two Novel Cutaneous Manifestations of the Post-immunotherapy Granulomatous Reactions Spectrum.

作者信息

Burillo-Martinez Sara, Morales-Raya Carlos, Prieto-Barrios Marta, Rodriguez-Peralto Jose-Luis, Ortiz-Romero Pablo-Luis

机构信息

Department of Dermatology, Hospital 12 de Octubre and Institute i+12, Medical School, Universidad Complutense, Madrid, Spain.

Department of Pathology, Hospital 12 de Octubre and Institute i+12, Medical School, Universidad Complutense, Madrid, Spain.

出版信息

JAMA Dermatol. 2017 Jul 1;153(7):721-722. doi: 10.1001/jamadermatol.2017.0581.

DOI:10.1001/jamadermatol.2017.0581
PMID:28467548
Abstract
摘要

相似文献

1
Pembrolizumab-Induced Extensive Panniculitis and Nevus Regression: Two Novel Cutaneous Manifestations of the Post-immunotherapy Granulomatous Reactions Spectrum.帕博利珠单抗诱导的广泛脂膜炎和痣消退：免疫治疗后肉芽肿反应谱的两种新型皮肤表现。
JAMA Dermatol. 2017 Jul 1;153(7):721-722. doi: 10.1001/jamadermatol.2017.0581.
2
Granulomatous Tumoral Melanosis Associated With Pembrolizumab Therapy: A Mimicker of Disease Progression in Metastatic Melanoma.与帕博利珠单抗治疗相关的肉芽肿性肿瘤性黑色素沉着症：转移性黑色素瘤中疾病进展的模仿者
Am J Dermatopathol. 2018 Jul;40(7):523-526. doi: 10.1097/DAD.0000000000001066.
3
Lupus-like cutaneous reaction following pembrolizumab: An immune-related adverse event associated with anti-PD-1 therapy.帕博利珠单抗治疗后出现的狼疮样皮肤反应：一种与抗程序性死亡蛋白 1（PD-1）治疗相关的免疫相关不良事件。
J Cutan Pathol. 2018 Jan;45(1):74-77. doi: 10.1111/cup.13059. Epub 2017 Nov 10.
4
A Rare Case of Pembrolizumab-Associated Granulomatous Panniculitis.一例罕见的帕博利珠单抗相关肉芽肿性脂膜炎病例。
Mayo Clin Proc. 2020 Nov;95(11):2315-2316. doi: 10.1016/j.mayocp.2020.08.037.
5
Follow-up on Programmed Cell Death 1 Inhibitor for Cutaneous Squamous Cell Carcinoma.程序性细胞死亡蛋白1抑制剂治疗皮肤鳞状细胞癌的随访
JAMA Dermatol. 2017 Jan 1;153(1):92-94. doi: 10.1001/jamadermatol.2016.3884.
6
Antiphospholipid Syndrome Following Pembrolizumab Treatment of Stage IIIB Unresectable Melanoma.帕博利珠单抗治疗IIIB期不可切除黑色素瘤后发生的抗磷脂综合征
JAMA Dermatol. 2018 Nov 1;154(11):1354-1356. doi: 10.1001/jamadermatol.2018.2770.
7
Pembrolizumab-induced lobular panniculitis in the setting of metastatic melanoma.帕博利珠单抗诱发的转移性黑色素瘤患者的小叶性脂膜炎
Cutis. 2020 Jan;105(1):E22-E23.
8
Final analysis of a randomised trial comparing pembrolizumab versus investigator-choice chemotherapy for ipilimumab-refractory advanced melanoma.一项比较帕博利珠单抗与研究者选择的化疗方案用于伊匹木单抗难治性晚期黑色素瘤的随机试验的最终分析。
Eur J Cancer. 2017 Nov;86:37-45. doi: 10.1016/j.ejca.2017.07.022.
9
[Two cases of granuloma annulare under anti-PD1 therapy].[抗PD1治疗下的两例环状肉芽肿]
Ann Dermatol Venereol. 2018 Feb;145(2):116-119. doi: 10.1016/j.annder.2017.11.005. Epub 2017 Dec 6.
10
Pembrolizumab-associated mucous membrane pemphigoid in a patient with Merkel cell carcinoma.一名默克尔细胞癌患者出现的帕博利珠单抗相关黏膜类天疱疮。
Br J Dermatol. 2018 Oct;179(4):993-994. doi: 10.1111/bjd.16780. Epub 2018 Jul 23.

引用本文的文献

1
Granulomatous and Sarcoid-like Immune-Related Adverse Events following CTLA4 and PD1 Blockade Adjuvant Therapy of Melanoma: A Combined Analysis of ECOG-ACRIN E1609 and SWOG S1404 Phase III Trials and a Literature Review.CTLA4和PD1阻断辅助治疗黑色素瘤后出现的肉芽肿性和类结节病样免疫相关不良事件：ECOG-ACRIN E1609和SWOG S1404 III期试验的联合分析及文献综述
Cancers (Basel). 2023 Apr 29;15(9):2561. doi: 10.3390/cancers15092561.
2
Suspected immune checkpoint inhibitor-induced pulmonary sarcoid reaction in metastatic renal cell carcinoma.转移性肾细胞癌中疑似免疫检查点抑制剂诱导的肺部结节病反应
Clin Case Rep. 2022 Jul 11;10(7):e5960. doi: 10.1002/ccr3.5960. eCollection 2022 Jul.
3
Sarcoid-like Granulomatosis Associated with Immune Checkpoint Inhibitors in Melanoma.
黑色素瘤中与免疫检查点抑制剂相关的结节病样肉芽肿病
Cancers (Basel). 2022 Jun 14;14(12):2937. doi: 10.3390/cancers14122937.
4
Erythema nodosum-like panniculitis associated with immune checkpoint inhibitor therapy: Two cases reporting a rare cutaneous adverse event.与免疫检查点抑制剂治疗相关的结节性红斑样脂膜炎：两例罕见皮肤不良事件报告
JAAD Case Rep. 2021 May 27;13:118-120. doi: 10.1016/j.jdcr.2021.05.002. eCollection 2021 Jul.
5
Sarcoid-like reaction in cases treated by checkpoint inhibitors.免疫检查点抑制剂治疗后发生类肉瘤样反应。
Med Oncol. 2021 Feb 18;38(3):29. doi: 10.1007/s12032-021-01477-y.
6
Management of dermatologic adverse events from cancer therapies: recommendations of an expert panel.癌症治疗引起的皮肤不良反应管理：专家小组建议
An Bras Dermatol. 2020 Mar-Apr;95(2):221-237. doi: 10.1016/j.abd.2020.01.001. Epub 2020 Feb 15.
7
Melanoma and Vitiligo: In Good Company.黑素瘤与白癜风：相伴相生。
Int J Mol Sci. 2019 Nov 15;20(22):5731. doi: 10.3390/ijms20225731.
8
Exclusive Cutaneous and Subcutaneous Sarcoidal Granulomatous Inflammation due to Immune Checkpoint Inhibitors: Report of Two Cases with Unusual Manifestations and Review of the Literature.免疫检查点抑制剂引起的单纯皮肤和皮下结节病样肉芽肿性炎症：两例不寻常表现病例报告及文献复习
Case Rep Dermatol Med. 2019 Jul 9;2019:6702870. doi: 10.1155/2019/6702870. eCollection 2019.
9
Immune checkpoint inhibitor-induced sarcoidosis-like granulomas.免疫检查点抑制剂诱导的类肉瘤样肉芽肿。
Int J Clin Oncol. 2019 Oct;24(10):1171-1181. doi: 10.1007/s10147-019-01490-2. Epub 2019 Jul 18.
10
Pembrolizumab-induced sarcoid granulomatous panniculitis and bullous pemphigoid in a single patient.帕博利珠单抗在一名患者中引发结节病样肉芽肿性脂膜炎和大疱性类天疱疮。
Clin Case Rep. 2019 Mar 11;7(4):773-775. doi: 10.1002/ccr3.2090. eCollection 2019 Apr.